Jefferies downgraded Beauty Health to Hold from Buy with a price target of $1.50, down from $11. The says investors did not know about the different iterations of the Syndeo system nor the reasons for the sudden slowdown in the business. The firm sees potential for more issues to arise, including the same problems happening to Syndeo 3.0, issues spreading to international, balance sheet risk with $700M debt due in 2026, and investor confidence impaired.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SKIN:
- Kraft Heinz upgraded, AMD initiated: Wall Street’s top analyst calls
- Beauty Health price target lowered to $3 from $8 at Stifel
- Beauty Health downgraded on limited visibility at William Blair
- Beauty Health downgraded to Underperform from Market Perform at Raymond James
- The BeautyHealth (NASDAQ:SKIN) Tanks on Disappointing Q3 Performance
